IL6 and Stroke: Additionally, design and conduct clinical trials for promising anti‐inflammatory or immunomodulatory strategies—for example, testing whether therapies like IL‐6 inhibitors or colchicine (an anti‐inflammatory drug) can reduce stroke incidence or improve outcomes, building on encouraging results from cardiovascular disease trials.